Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3A pseudogene 11 (RPS3AP11) is a processed pseudogene derived from the ribosomal protein S3A gene (RPS3A). Like other ribosomal protein pseudogenes, it is a byproduct of gene duplication or retrotransposition in the genome and does not encode a functional ribosomal protein. Pseudogenes such as RPS3AP11 usually have high sequence similarity to their parent gene but contain disabling mutations that render them non-coding. RPS3AP11, like other ribosomal pseudogenes, is not known to have any biological or pathological functions and is not considered a therapeutic target. The functional RPS3A gene encodes a component of the 40S ribosomal subunit and participates in protein synthesis, but its pseudogenes, including RPS3AP11, are gene relics that do not produce functional proteins and have no established cellular roles. Pseudogenes are not targets for drugs or therapeutic interventions, nor are they considered biomarkers or associated with specific safety issues; they are largely genomic "fossils".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPS3A pseudogene 11 (RPS3AP11).